There are no clinical studies on the efficacy, safety, or dosing of GLP-1 patches, but they will likely follow the titrating dosing method, similar to GLP-1 injections
Additionally, hypoglycaemia (low blood sugar), though less common with GLP-1 agonists than with insulin or sulphonylureas, can cause irritability, confusion, and mood changes when it does occur, particularly in patients taking concurrent diabetes medications
Both medications are approved for treating obesity or overweight individuals with at least one weight-related comorbidity
When starting on semaglutide for weight loss management, here are some things you can expect: Initial Side Effects
Data suggest GLP-1s help clear toxic proteins, reduce inflammation, improve brain energy use, and protect cell connections
Paulescu published his results the following year and then took out a Romanian patent on his technique in April 1922